The Efficacy and Safety of Chemotherapy-Based Stem Cell Mobilization in Multiple Myeloma Patients That Are "Poor Responder" to Induction- The Mayo Clinic Experience.
暂无分享，去创建一个
D. Dingli | A. Dispenzieri | Shaji K. Kumar | M. Gertz | M. Lacy | W. Hogan | F. Buadi | T. Kourelis | R. Warsame | W. Gonsalves | Eli Muchtar | I. Vaxman | E. Jacob | K. Prashant